Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Rev Med Liege ; 57(3): 171-5, 2002 Mar.
Article in French | MEDLINE | ID: mdl-12014266

ABSTRACT

The aim of this work was to investigate if sex, age, family history, season and hypothyroidism have any influence on the type of episodes (manic, depressive, mixed) seen in bipolar patients. This retrospective study concerns a sample of 208 patients with a diagnosis of bipolar disorder (type I or II), who were admitted in one of two psychiatric centers between July 1996 and June 2000. The sex-ratio was 2.8 females for 1 male. Sex, family history and hypothyroidism were not associated with any type of episode. A higher percentage of depressive episodes was observed in the patients who were older than 50 and the average age of depressive patients was higher than that of other patients. There was no seasonal pattern in this study and the season did not influence the type of episode. The results indicate no influence of sex, season, family history and hypothyroidism on the type of episode presented. On the opposite, age seems to favour depression episode.


Subject(s)
Bipolar Disorder/etiology , Bipolar Disorder/pathology , Genetic Predisposition to Disease , Hypothyroidism/complications , Adult , Aged , Aged, 80 and over , Family Health , Female , Humans , Male , Middle Aged , Retrospective Studies , Seasons , Severity of Illness Index , Sex Factors
2.
Acta Psychiatr Belg ; 86(2): 152-76, 1986.
Article in English | MEDLINE | ID: mdl-2873713

ABSTRACT

A total of 95 schizophrenic or manic patients received zuclopenthixol (cis(Z)-clopenthixol) either intramuscularly or orally during a period of 2 to 4 weeks in mean daily doses of 25 mg (i.m.) or 75 mg (p.o.). They were rated with the CGI, VAS, MSS, BPRS, and AMDP scales. Zuclopenthixol proved to be a potent antimanic, anti-aggressive and antidelusional neuroleptic already from the second day of injection. Very few anticholinergic and extrapyramidal side effects as well as little somnolence were seen and the local tolerance was excellent. The 14-factor AMDP profile proved valid, sensitive to change and highly differentiated.


Subject(s)
Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Clopenthixol/therapeutic use , Schizophrenia/drug therapy , Thioxanthenes/therapeutic use , Administration, Oral , Animals , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/pharmacology , Bipolar Disorder/diagnosis , Clopenthixol/administration & dosage , Clopenthixol/pharmacology , Female , Humans , Injections, Intramuscular , Male , Mice , Psychiatric Status Rating Scales , Rabbits , Rats , Schizophrenia/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...